Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

New York Times - Nov 17, 2026

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.

Read full article

More News

Deck Biz

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Sign Up